The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

GW Pharmaceuticals PLC

Nasdaq: GWPH
Last

(U.S.) $124.91

Today's change-1.15 -0.91%
Updated September 27 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

GW Pharmaceuticals PLC

Nasdaq: GWPH
Last

(U.S.) $124.91

Today's change-1.15 -0.91%
Updated September 27 4:00 PM -4GMT. Delayed by at least 15 minutes.

Reversal following new 52-week high

GW Pharmaceuticals PLC closed lower Tuesday, dropping (U.S.)$1.15 or 0.91% to (U.S.)$124.91 after setting a new 52-week high. Over the last five days, shares have gained 15.35% and are currently 1.99% off of the 52-week high. Shares have outperformed the S&P 500 by 14.27% during the last year.

Key company metrics

  • Open(U.S.) $125.60
  • Previous close(U.S.) $126.06
  • High(U.S.) $127.45
  • Low(U.S.) $122.61
  • Bid / Ask(U.S.) $123.00 / (U.S.) $126.55
  • YTD % change+79.88%
  • Volume1,012,669
  • Average volume (10-day)849,101
  • Average volume (1-month)788,891
  • Average volume (3-month)608,448
  • 52-week range(U.S.) $35.83 to (U.S.) $127.45
  • Beta2.91
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEG0.84×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$3.50
Updated September 27 4:00 PM -4GMT. Delayed by at least 15 minutes.
S&P TSX0.42%Sector:Industry:

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue2346
Total other revenue--------
Total revenue2346
Gross profit2235
Total cost of revenue1111
Total operating expense21252524
Selling / general / administrative6345
Research & development26262425
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-18-22-21-19
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-18-22-21-19
Income after tax-12-17-18-12
Income tax, total-6-5-3-6
Net income-12-17-18-12
Total adjustments to net income--------
Net income before extra. items-12-17-18-12
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-12-17-18-12
Inc. avail. to common incl. extra. items-12-17-18-12
Diluted net income-12-17-18-12
Dilution adjustment--------
Diluted weighted average shares263263261261
Diluted EPS excluding extraordinary itemsvalue per share-0.05-0.06-0.07-0.05
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.05-0.06-0.07-0.05